Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity
- PMID: 1780171
- DOI: 10.1017/s0031182000059850
Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity
Abstract
A comparison was made of the long-term impact of different methods of administration of chemotherapy (oxamniquine, 30 mg/kg in divided doses; or praziquantel, 40 mg/kg) on prevalence and intensity of Schistosoma mansoni infection in four areas in Kangundo Location, Machakos District, Kenya. In Area A, treatment was offered in October 1983 and again in April 1985 to all infected individuals. In Area H, treatment was offered in April 1985 to individuals excreting greater than or equal to 100 eggs per gram (epg) of faeces. In Area S, treatment was offered in April 1985 to all infected school children, within the framework of the primary schools. In the witness area, Area W, treatment was given in April 1985, for ethical reasons, to a small number of individuals excreting greater than or equal to 800 epg. Prevalence and intensities of infection were subsequently monitored at yearly intervals for three complete post-treatment years. In the Area S schools, clinical examination was also carried out at yearly intervals. Treatment of all infected individuals on two occasions (Area A) was the most effective and long-lasting way of reducing prevalence and intensity of infection. In this area, however, some earlier interventions had been carried out and pre-treatment intensities were lower than in the other areas. Treatment only of infected schoolchildren (Area S) also had a marked and prolonged effect, comparable to or better than treatment of individuals with heavy infections (Area H). Treatment of infected schoolchildren also caused a persistent reduction in the prevalence of hepatomegaly, and there was suggestive evidence from intensities of infection in community stool surveys (but not from incidence rates) of an effect on transmission. In all study areas, reinfection was most rapid and most intense among children. These findings are discussed in the light of theoretical considerations and of results from other studies, both on schistosomiasis and on intestinal helminths. We conclude that, in areas of low morbidity such as Kangundo, chemotherapy of schoolchildren only, at intervals of up to 3 years, is a satisfactory way of producing a long-term reduction in both intensity of infection and morbidity.
Similar articles
-
Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.Trans R Soc Trop Med Hyg. 1989 Mar-Apr;83(2):219-28. doi: 10.1016/0035-9203(89)90655-x. Trans R Soc Trop Med Hyg. 1989. PMID: 2514474 Clinical Trial.
-
A 13-year follow-up of treatment and snail control in an area endemic for Schistosoma mansoni in Brazil: incidence of infection and reinfection.Bull World Health Organ. 1993;71(2):197-205. Bull World Health Organ. 1993. PMID: 8490983 Free PMC article.
-
Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.Parasit Vectors. 2016 Oct 24;9(1):560. doi: 10.1186/s13071-016-1833-6. Parasit Vectors. 2016. PMID: 27772528 Free PMC article.
-
Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas.East Afr Med J. 2002 Jan;79(1):29-33. doi: 10.4314/eamj.v79i1.8921. East Afr Med J. 2002. PMID: 12380867
-
Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.Trop Geogr Med. 1994;46(4 Spec No):209-19. Trop Geogr Med. 1994. PMID: 7825223 Clinical Trial.
Cited by
-
Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations.Parasit Vectors. 2017 Apr 28;10(1):213. doi: 10.1186/s13071-017-2141-5. Parasit Vectors. 2017. PMID: 28454578 Free PMC article.
-
What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?Parasit Vectors. 2015 Oct 22;8:553. doi: 10.1186/s13071-015-1157-y. Parasit Vectors. 2015. PMID: 26489831 Free PMC article.
-
Anthelmintics. A comparative review of their clinical pharmacology.Drugs. 1997 May;53(5):769-88. doi: 10.2165/00003495-199753050-00004. Drugs. 1997. PMID: 9129865 Review.
-
Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa.Parasit Vectors. 2015 Oct 22;8:529. doi: 10.1186/s13071-015-1144-3. Parasit Vectors. 2015. PMID: 26489408 Free PMC article.
-
The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni.PLoS Negl Trop Dis. 2018 Oct 8;12(10):e0006717. doi: 10.1371/journal.pntd.0006717. eCollection 2018 Oct. PLoS Negl Trop Dis. 2018. PMID: 30296257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous